News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
849,598 Results
Type
Article (86631)
Company Profile (703)
Press Release (762262)
Multimedia
Podcasts (135)
Webinars (17)
Section
Business (232738)
Career Advice (4129)
Deals (39732)
Drug Delivery (129)
Drug Development (91022)
Employer Resources (198)
FDA (18136)
Job Trends (17348)
News (396602)
Policy (39777)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (97)
Alliances (56895)
ALS (109)
Alzheimer's disease (1528)
Antibody-drug conjugate (ADC) (173)
Approvals (18086)
Artificial intelligence (356)
Autoimmune disease (32)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (121)
Biotechnology (481)
Bladder cancer (91)
Brain cancer (34)
Breast cancer (343)
Cancer (2703)
Cardiovascular disease (225)
Career advice (3536)
Career pathing (34)
CAR-T (193)
Cell therapy (535)
Cervical cancer (22)
Clinical research (73750)
Collaboration (985)
Company closure (3)
Compensation (606)
Complete response letters (30)
COVID-19 (2889)
CRISPR (58)
C-suite (296)
Cystic fibrosis (113)
Data (2639)
Decentralized trials (2)
Denatured (47)
Depression (60)
Diabetes (319)
Diagnostics (6948)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (144)
Drug shortages (34)
Duchenne muscular dystrophy (115)
Earnings (97393)
Editorial (47)
Employer branding (25)
Employer resources (168)
Events (130907)
Executive appointments (846)
FDA (19673)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (897)
Gene editing (135)
Generative AI (36)
Gene therapy (401)
GLP-1 (876)
Government (5195)
Grass and pollen (6)
Guidances (179)
Healthcare (20903)
Huntington's disease (27)
IgA nephropathy (33)
Immunology and inflammation (163)
Immuno-oncology (3)
Indications (32)
Infectious disease (3057)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (62)
Intellectual property (110)
Interviews (813)
IPO (17865)
IRA (52)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (13)
Labor market (50)
Layoffs (576)
Leadership (25)
Legal (10124)
Liver cancer (82)
Lung cancer (386)
Lymphoma (185)
Machine learning (9)
Management (65)
Manufacturing (394)
MASH (90)
Medical device (14669)
Medtech (14674)
Mergers & acquisitions (22494)
Metabolic disorders (851)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (127)
Neuropsychiatric disorders (37)
Neuroscience (2199)
NextGen: Class of 2025 (7685)
Non-profit (5086)
Now hiring (44)
Obesity (449)
Opinion (281)
Ovarian cancer (88)
Pain (108)
Pancreatic cancer (96)
Parkinson's disease (178)
Partnered (25)
Patents (275)
Patient recruitment (131)
Peanut (52)
People (65478)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22769)
Phase II (32034)
Phase III (24105)
Pipeline (1561)
Policy (199)
Postmarket research (3552)
Preclinical (10285)
Press Release (72)
Prostate cancer (128)
Psychedelics (39)
Radiopharmaceuticals (275)
Rare diseases (471)
Real estate (7396)
Recruiting (75)
Regulatory (26920)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (8)
RNA editing (9)
RSV (51)
Schizophrenia (88)
Series A (155)
Series B (105)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (78)
Tariffs (61)
The Weekly (86)
Vaccines (845)
Venture capitalists (48)
Weight loss (310)
Women's health (44)
Worklife (20)
Date
Today (115)
Last 7 days (639)
Last 30 days (3626)
Last 365 days (35136)
2025 (15137)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (66)
Alaska (7)
Arizona (275)
Arkansas (14)
Asia (50296)
Australia (8848)
California (7185)
Canada (2238)
China (627)
Colorado (308)
Connecticut (323)
Delaware (179)
Europe (115427)
Florida (1053)
Georgia (246)
Hawaii (1)
Idaho (65)
Illinois (688)
India (31)
Indiana (361)
Iowa (15)
Japan (197)
Kansas (115)
Kentucky (30)
Louisiana (16)
Maine (72)
Maryland (1038)
Massachusetts (5500)
Michigan (262)
Minnesota (453)
Mississippi (3)
Missouri (94)
Montana (32)
Nebraska (26)
Nevada (76)
New Hampshire (72)
New Jersey (2002)
New Mexico (31)
New York (2020)
North Carolina (1194)
North Dakota (10)
Northern California (3101)
Ohio (237)
Oklahoma (16)
Oregon (48)
Pennsylvania (1550)
Puerto Rico (17)
Rhode Island (38)
South America (1653)
South Carolina (31)
South Dakota (1)
Southern California (2647)
Tennessee (118)
Texas (1081)
United States (27252)
Utah (210)
Virginia (193)
Washington D.C. (77)
Washington State (647)
West Virginia (4)
Wisconsin (80)
There are 849,598 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Announces Publication of Full Phase I BEXMAB Study Data in Lancet Haematology
May 30, 2025
·
6 min read
Press Releases
AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575
May 30, 2025
·
3 min read
Press Releases
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights
May 30, 2025
·
12 min read
Press Releases
Kymera Therapeutics to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025
May 30, 2025
·
3 min read
Press Releases
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
May 30, 2025
·
5 min read
Press Releases
Bruker Corporation to Present at the Jefferies Global Healthcare Conference
May 30, 2025
·
1 min read
Layoffs
Stealth Cuts 30% of Workforce Following FDA Rejection, Still Eyes Barth Approval
Although the FDA has rejected Stealth’s new drug application for Barth syndrome candidate elamipretide, the agency identified a potential accelerated approval pathway. The company has pared down its staff to conserve resources to fund a potential resubmission.
May 30, 2025
·
2 min read
·
Angela Gabriel
Layoff Tracker
iTeos Winding Down Operations
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 30, 2025
·
215 min read
·
BioSpace Editorial Staff
Immunology and inflammation
Sanofi, Regeneron Shares Tumble as Dupixent Follow-Up Fails Phase III COPD Test
Analysts at Truist Securities admitted that the result for itepekimab, which the companies were hoping to follow their blockbuster Dupixent in the I&I space, was “contrary to our expectations—we were wrong.”
May 30, 2025
·
3 min read
·
Annalee Armstrong
Lung Cancer
Summit’s Bispecific Misses Survival Endpoint in Global Phase III Trial but Analysts Remain Optimistic
Despite mixed results, analysts maintained faith in ivonescimab’s ability to cross over between Eastern and Western patient populations.
May 30, 2025
·
3 min read
·
Nick Paul Taylor
1 of 84,960
Next
